Sign in
4

Changes in Ownership

Avalyn Pharma Inc. Filed Acc 0001193125-26-201870

Options or other derivatives

  • Director acquired 26,978 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Turner Heather D Director 2026-04-29 Grant or award · Stock Option (Right to Buy) +26,978 26,978 D
Loading xslF345X06/ownership.xml…